Access Data

Back to the List

Type(s) of Cancer
Leukemia/Lymphoma

Study Phase

Phase 2B

Study Completion Date
2006

NCT00301821Uploaded 08-28-2017

Available for Download

PDS UID: Lymphom_Allianc_2006_212

N/A

Provider Information

Provider Data DescriptionTo prospectively assess the efficacy of combination of CHOP with epratuzumab and rituximab (ER-CHOP), as measured by 12-month, event-free survival (EFS12), in patients with previously untreated stages II, III, and IV diffuse large B-cell lymphoma. To assess the use of PET scan routinely early in treatment and post-completion of chemotherapy and thereby assess the functional CR rate (CR/PR or stable by CT scan and PET negative). To assess the safety of ER-CHOP.

SponsorAlliance for Clinical Trials in Oncology

Data ProviderAlliance for Clinical Trials in Oncology

Partial set or SubsetOriginal Data

Patients in dataset107

# of Patients ControlN/A

# of Patients Experimental107

DOIhttps://doi.org/10.34949/vtkf-jr80

CDISC StandardADS

Study ArmsExperimental arm data only

Clinical Trials.gov Information

Brief SummaryN/A

ConditionsN/A

Intervention TypeDrug, Biologics

Drug(s)N/A

Total EnrolledN/A

RandomizationN/A

Blinding MethodN/A

Arms InterventionN/A

Secondary IDN/A

PubMed (PMID)N/A

Collaborator(s)N/A

Region(s)N/A

Age RangeN/A

Files:

PROTOCOLN0489Prot_06Aug2008.pdf

CRFFormsPacket_21Sep2007.pdf

DATA DICTIONARYn0489_datasphere_datadictionary.docx

DATA (ACTIVE ARM)outcome17mar24.sas7bdat

DATA (ACTIVE ARM)events.sas7bdat

SAS® provides free access to powerful tools for Project Data Sphere users.

VDMML

LSAF

SAS tools include VDMML (Visual Data Mining & Machine Learning) and LSAF (Life Sciences Analytics Framework). You can access these datasets directly via this secure analytics space. Please contact us with any questions/issues in working in this environment

VDMML: SAS Studio, Model Studio, Visual Analytics, Enterprise Miner, embedded support for Python & R
LSAF: Transformations, analytics and reporting of clinical trial data

These data have been curated or enriched with additional data elements such as the MEPS (AHRQ's Medical Expenditure Panel Survey) data prepared by RTI International and the Prostate Dream Challenge.

PDS' open access sharing model has generated a significant volume of discovery within oncology. If available, each contribution includes a summary of known peer-reviewed journal publications and you can explore all of them here.

Become a data provider to share the results of your cancer-related clinical studies.

Share Data